Audit 28603

FY End
2022-12-31
Total Expended
$6.11M
Findings
0
Programs
2
Organization: Aids Vaccine Advocacy Coalition (NY)
Year: 2022 Accepted: 2023-09-28
Auditor: Eisneramper LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
98.001 Usaid Foreign Assistance for Programs Overseas $749,639 Yes 0
93.855 Allergy, Immunology and Transplantation Research $131,019 - 0

Contacts

Name Title Type
PJUPN27NDK71 Abigail Smith Auditee
9177963505 William Epstein Auditor
No contacts on file

Notes to SEFA

Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of AVAC under programs of the federal government for the year ended December 31, 2022. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of AVAC, it is not intended to and does not present the financial position, changes in net assets, or cash flows of AVAC. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate.